Search

everythinglearnresearchcommunity

for

Search:↓

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

Skin diseases are common in HIV patients and could help detect HIV early in Ethiopia.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

Male hair loss is mainly due to thinner hair, not less hair.

Male-pattern hair loss is normal, often involves hormone effects on hair follicles, and can be treated with medication or surgery, but new treatments are being researched.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Taking vitamin C and vitamin E twice a day can help prevent sunburn and DNA damage from UVB exposure.

Adolescents with severe alopecia incur significantly higher healthcare costs.

A 12-year-old boy's hair fully regrew after 8 weeks of treatment for tinea capitis, and dermoscopy was useful for diagnosis and monitoring.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Zolpidem shows up in hair from the top back of the head after one dose and fades over time, suggesting it gets into hair through blood and sweat.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.